Long term follow-up and patterns of response of ALT in patients with chronic hepatitis NANB/C treated with recombinant interferon-alpha Seguimento tardio e padrões de resposta da ALT em pacientes com hepatite crônica NANB/C tratados com interferon-alfa

Autor: L.C. da Silva, S.K. Ono, L.E.P. Fonseca, F.J. Carrilho, L.C.A. Mendes, A.V.C. França, C.L.A. Madruga, A.A. Laudanna

Publikováno v: Revista do Instituto de Medicina Tropical de São Paulo, Vol 37, Iss 3, Pp 239-243 (1995)

The response to interferon treatment in chronic hepatitis NANB/C has usually been classified as complete, partial or absent, according to the behavior of serum alanine aminotransferase (ALT). However, a more detailed observation of the enzymatic acti

Externí odkaz: https://doaj.org/article/74f6862fe98146388932e933e3df91ae

Filtrado do meio de cultivo do cogumelo Pycnoporus sanguineus no controle de Alternaria sp.

Autor: Belo Pereira, Leonel Bismarck¹, Santos de Jesus, Michele¹, Almeida Correia, David Patrick², Schervinski Villwock, Ana Paula³, Almeida Viégas, Pedro Roberto⁴, Helena Marino, Regina⁵ rehmarino@hotmail.com

Publikováno v: Revista em Agronegócio e Meio Ambiente. jul-set2024, Vol. 17 Issue 3, p1-14. 14p.

Development and validation of claims-based algorithms for estimating gestational age of spontaneous abortion and termination.

Autor: Zhu Y; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Hernandez-Diaz S; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Bateman BT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, CA, USA., Gray KJ; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington Medical Center, Seattle, WA, United States., Alt EM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Biostatistics, University of North Carolina at Chapel Hill., Straub L; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Taylor LG; Division of Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA., Ouellet-Hellstrom R; Division of Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA., Ma Y; Division of Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA., Qiang Y; Division of Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA., Vine S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Mogun H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Hua W; Department of Biostatistics, University of North Carolina at Chapel Hill., Huybrechts KF; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Publikováno v: American journal of epidemiology [Am J Epidemiol] 2024 Sep 24. Date of Electronic Publication: 2024 Sep 24.

Rejoinder to the discussion on "LEAP: the latent exchangeability prior for borrowing information from historical data".

Autor: Alt EM; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27516, United States., Chang X; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27516, United States., Jiang X; Amgen, Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, United States., Liu Q; Amgen, Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, United States., Mo M; Amgen, Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, United States., Xia HA; Amgen, Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, United States., Ibrahim JG; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27516, United States.

Publikováno v: Biometrics [Biometrics] 2024 Jul 01; Vol. 80 (3).

A Bayesian approach to study design and analysis with type I error rate control for response variables of mixed types.

Autor: Alt EM; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Psioda MA; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Ibrahim JG; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Publikováno v: Statistics in medicine [Stat Med] 2023 May 20; Vol. 42 (11), pp. 1722-1740. Date of Electronic Publication: 2023 Mar 17.